Decrease in revenue but increase in profits! Contemporary Amperex Technology will generate over 50 billion in 2024｜Interpretations
① In 2024, Contemporary Amperex Technology's performance will see a decrease in revenue but an increase in profit, with a Net income reaching 50.7 billion yuan; ② The Battery Business remains the largest source of revenue for Contemporary Amperex Technology; ③ The inventory impairment reserve of Contemporary Amperex Technology has significantly increased compared to the previous year.
Dramatic scene! Shanghai Kinetic Medical is being sued by the chairman's own company, escalating the equity repurchase dispute to judicial contention.
① Shanghai Xinchengyi, controlled by Yuan Zheng, has sued Shanghai Kinetic Medical, chaired by Yuan Zheng, requesting the annulment of the previous Board of Directors resolution; ② Lawyers believe that share buyback is a significant matter for the company, directly affecting the interests of small and medium shareholders, and this lawsuit also sends a signal of corporate governance risk to the market; ③ In the current predicament of Shanghai Kinetic Medical, the protection of small and medium investors' interests is urgent and it is necessary to ensure that the opinions of all shareholders are treated fairly.
The "King Ning" is heading towards a new battlefield.
Reconstruct the Global Industry Chain.
New Phase Micro plans to acquire 100% equity of AiXieSheng Technology. The target company's revenue is expected to exceed 1.2 billion yuan in 2024. Shenzhen Yitoa Intelligent Control had previously intended to make an acquisition.
① New Xiangwei plans to acquire 100% equity of Shenzhen Ai Xie Sheng Technology Co., Ltd. through the issuance of shares, convertible bonds, and cash payment; ② New Xiangwei will form a positive synergistic and complementary relationship with the symbol company in product categories, Technology research and development, customer resources and sales channels, and supply chain integration.
Brokerage morning meeting highlights: It is recommended to pay attention to companies in the humanoid robot industry that have the capability for low stock price bulk supply of components.
In today's Brokerage morning meeting, China Securities Co.,Ltd. suggested focusing on companies in the humanoid robot Industry that have the capacity for low stock price mass supply of components; Tianfeng stated that the wind turbine Sector will undergo a value reassessment; Galaxy Securities believes that the peak season de-stocking turning point in the non-ferrous Industry is emerging, and the spring market is expected to unfold.
Special Treat Jiahua is on the brink of being delisted, with losses of 4.3 billion over six years. How can it turn around while being mired in the mud of salmon farming?
① ST Jiawo will become the first company on the A-share market to receive a non-standard audit opinion in 2025. The company will also be subject to delisting risk warnings; ② The turning point in performance appeared in 2019, when the company acquired the salmon business through a significant investment; ③ The company previously went public through Wanfushengke, creating a classic case of "turnaround in adversity." Now faced with difficulties again, how will it turn around this time?
HopelessChi : the pegging will be broken in due time. short selling globally is more aggressive than one country wilful act.